-
Mashup Score: 2Vascular Comorbidity in MS Linked to Atrophy, Functional Decline - 4 year(s) ago
People with multiple sclerosis and two vascular comorbidities showed significantly lower gray matter and neurofunctional status vs those with no such comorbidities.
Source: MedscapeCategories: Latest Headlines, NeurologyTweet
-
Mashup Score: 2TDP-43 Protein Declines Years Before Death in Alzheimer's - 4 year(s) ago
New data show TDP-43 levels in the brain start to decline almost 20 years before death in Alzheimer’s disease and are linked to the rate of hippocampal atrophy, independently of other biomarkers.
Source: MedscapeCategories: Latest Headlines, NeurologyTweet-
Brain levels of TDP-43, a key factor in neurodegeneration that occurs with #Alzheimers disease, declines nearly 2 decades prior to the end of life. https://t.co/AKvAKasShM #ANA2020 https://t.co/sZ3RDKsfvC
-
-
Mashup Score: 7Gantenerumab Affects Key Alzheimer's Biomarkers: DIAN-TU - 4 year(s) ago
Despite failed primary cognitive outcomes, secondary measures from the DIAN-TU trial show significant effects on amyloid, other biomarkers; dose escalation may be key.
Source: MedscapeCategories: General Medicine News, Latest HeadlinesTweet-
New data from the phase 2/3 DIAN-TU trial shows notable improvements in key Alzheimer's biomarkers with gantenerumab, despite trial failure to meet its primary endpoint of slowing cognitive decline. https://t.co/Ce0X1BHvh9 #ANA2020
-
-
Mashup Score: 1Gantenerumab Affects Key Alzheimer's Biomarkers: DIAN-TU - 4 year(s) ago
Despite failed primary cognitive outcomes, secondary measures from the DIAN-TU trial show significant effects on amyloid, other biomarkers; dose escalation may be key.
Source: MedscapeCategories: Latest Headlines, PsychiatryTweet-
New data from the phase 2/3 DIAN-TU trial shows notable improvements in key #Alzheimers biomarkers with gantenerumab, despite trial failure to meet its primary endpoint of slowing cognitive decline. https://t.co/sJ5k6GxDCy #ANA2020
-
-
Mashup Score: 3Vascular Comorbidity in MS Linked to Atrophy, Functional Decline - 4 year(s) ago
People with multiple sclerosis and two vascular comorbidities showed significantly lower gray matter and neurofunctional status vs those with no such comorbidities.
Source: MedscapeCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Vascular comorbidities, including diabetes and #hypertension, are linked to significantly lower measures of neurologic function in #multiplesclerosis. https://t.co/tjfOIuTo7B #ANA2020
-
-
Mashup Score: 1Gantenerumab Affects Key Alzheimer's Biomarkers: DIAN-TU - 4 year(s) ago
Despite failed primary cognitive outcomes, secondary measures from the DIAN-TU trial show significant effects on amyloid, other biomarkers; dose escalation may be key.
Source: MedscapeCategories: Latest Headlines, NeurologyTweet-
New data from phase 2/3 DIAN-TU trial shows notable improvements in key Alzheimer's biomarkers with gantenerumab, despite trial failure to meet its primary endpoint of slowing cognitive decline. https://t.co/Ya5xXBnTEb #ANA2020
-
-
Mashup Score: 1‘Landmark’ study pushed detection of covert consciousness in TBI - 4 year(s) ago
There is now hope of improving outcomes and even sparing lives of patients who may otherwise have been mistakenly assessed as having no chance of recovery.
Source: www.mdedge.comCategories: Latest Headlines, NeurologyTweet-
Study on detecting covert consciousness in traumatic brain injuries. https://t.co/03rJpPM4mm #ANA2020 #TBI #Brainhealth https://t.co/cMBcs1zOM4
-
-
Mashup Score: 5'Landmark' Study Pushed Detection of Covert Consciousness in TBI - 4 year(s) ago
Recent research has led to a “sea change” in guidelines and accelerated momentum in research to better detect signs of consciousness after traumatic brain injury (TBI).
Source: MedscapeCategories: General Medicine News, Latest HeadlinesTweet-
NEJM: Some compelling advances in the ability to detect signs of consciousness in unconscious TBI patients. https://t.co/xjrUfgDLPO #ANA2020
-
-
Mashup Score: 3'Landmark' Study Pushed Detection of Covert Consciousness in TBI - 4 year(s) ago
Recent research has led to a “sea change” in guidelines and accelerated momentum in research to better detect signs of consciousness after traumatic brain injury (TBI).
Source: MedscapeCategories: Latest Headlines, NeurologyTweet-
NEJM: Some compelling advances in the ability to detect signs of consciousness in unconscious TBI patients. https://t.co/3YCzPNHsiP #ANA2020
-
-
Mashup Score: 1Istradefylline as an Adjunct to Levodopa in Parkinson’s Disease - 4 year(s) ago
Interview with Mark Hallett MD
Source: PracticeUpdateCategories: General Medicine News, Latest HeadlinesTweet-
Istradefylline as an Adjunct to Levodopa in #Parkinson’s Disease 📽️ #ANA2020 interview with Dr. Mark Hallett 👇 @TheNewANA1 @NIH https://t.co/7Yp02LNIlB
-
Vascular comorbidities, including diabetes and hypertension, are linked to significantly lower measures of neurologic function in multiple sclerosis. #ANA2020 https://t.co/oB5XwoHY8j